Charles Elliott Sigal - Jun 8, 2022 Form 4 Insider Report for Surface Oncology, Inc. (SURF)

Role: Director
Signature: /s/ Jessica Fees, as Attorney-in-Fact
Stock symbol: SURF
Transactions as of: Jun 8, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/10/2022, 08:00 PM
Previous filing: May 25, 2022
Next filing: Jul 1, 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SURF	Stock Option (Right to Buy)	Award	$0	+24K		$0.00	24K	Jun 8, 2022	Common Stock	24K	$2.01	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Options shall vest in twelve equal monthly installments following the date of grant or, if earlier, upon the date of the next Annual Meeting; provided, however, that all vesting shall cease if the director resigns from the Board of Directors or otherwise ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting.